Ganga Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 11, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	71	71	49	118	57	42
Market Cap Growth	147.74%	44.22%	-58.34%	108.67%	35.90%	36.67%
Enterprise Value	86	86	60	135	75	59
Last Close Price	12.00	12.00	10.17	24.41	13.93	10.25
PE Ratio	70.59	69.89	62.24	253.25	143.94	109.87
PS Ratio	2.51	2.51	1.87	4.32	2.19	1.67
PB Ratio	0.85	0.85	0.69	1.67	1.04	0.77
P/TBV Ratio	0.85	0.85	0.69	1.67	1.04	0.77
EV/Sales Ratio	3.05	3.05	2.28	4.94	2.91	2.36
EV/EBITDA Ratio	220.58	220.58	-	234.37	1591.29	139.49
EV/EBIT Ratio	-	-	-	1606.20	-	-
Debt / Equity Ratio	0.13	0.13	0.20	0.19	0.34	0.36
Debt / EBITDA Ratio	27.88	27.88	-	23.54	386.63	45.76
Net Debt / Equity Ratio	0.12	0.12	0.16	0.19	0.33	0.35
Net Debt / EBITDA Ratio	26.39	26.39	-9.62	23.03	380.49	45.28
Net Debt / FCF Ratio	-0.77	-0.77	-1.65	-1.03	-32.89	-8.46
Asset Turnover	0.30	0.30	0.30	0.33	0.32	0.32
Inventory Turnover	1.11	1.11	1.01	1.03	1.07	1.13
Quick Ratio	0.81	0.81	0.76	0.80	0.49	0.54
Current Ratio	6.12	6.12	4.28	4.81	2.72	2.91
Return on Equity (ROE)	1.31%	1.31%	1.11%	0.75%	0.72%	0.70%
Return on Assets (ROA)	-0.11%	-0.11%	-1.16%	0.06%	-0.40%	-0.10%
Return on Invested Capital (ROIC)	-0.14%	-0.15%	-1.63%	0.08%	-0.52%	-0.13%
Return on Capital Employed (ROCE)	-0.20%	-0.20%	-2.20%	0.10%	-0.80%	-0.20%
Earnings Yield	1.43%	1.43%	1.61%	0.40%	0.69%	0.91%
FCF Yield	-19.00%	-19.00%	-13.74%	-10.90%	-0.97%	-5.42%
Buyback Yield / Dilution	9.69%	9.69%	-	-62.79%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.